Growth impairment shows an age-dependent pattern in boys with chronic kidney disease

Miroslav Zivicnjak1, Doris Franke, Guido Filler

  • 1Department of Pediatric Nephrology, Children's Hospital of Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. zivicnjak.miroslav@mh-hannover.de

Insights

This study reveals a distinct age-dependent growth pattern in boys with chronic kidney disease (CKD), with leg length being the most sensitive indicator. This pattern is consistent across CKD severity and treatments.

Area of Science:

  • Pediatric Nephrology
  • Growth and Development
  • Chronic Kidney Disease (CKD)

Background:

  • Longitudinal body growth in pediatric chronic kidney disease (CKD) remains understudied using detailed anthropometric methods.
  • Understanding growth patterns is crucial for managing long-term health outcomes in children with CKD.

Purpose of the Study:

  • To investigate the impact of chronological age on longitudinal body growth in boys with CKD.
  • To identify specific growth patterns and evaluate anthropometric indicators of growth failure.

Main Methods:

  • Prospective data collection over 7 years on 190 boys (3-21 years) with congenital/hereditary CKD (≥ stage 2 by age 10).
  • Measurement of four linear growth components: body height (HT), sitting height (SHT), arm length (AL), and leg length (LL).
  • Analysis of growth patterns irrespective of CKD severity and treatment modalities (conservative, rhGH, transplantation).

Main Results:

  • Pediatric male CKD patients exhibit a specific age-dependent growth pattern: severe failure in early childhood, pre-pubertal acceleration, pubertal slowing, and late adolescent/early adulthood acceleration.
  • Leg length (LL) demonstrated the most dynamic growth changes and emerged as the best indicator of statural growth.
  • Observed growth pattern was consistent across varying CKD degrees and treatments.

Conclusions:

  • A unique age-dependent physical growth pattern exists in pediatric male CKD patients.
  • Leg length is a key indicator for assessing statural growth in this population.
  • This identified growth pattern is essential for evaluating individual growth and treatment efficacy, including recombinant human growth hormone (rhGH) therapy.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...